BioSpace News Archive

Illustration showing male, female choosing from three paths

Career Advice

12 Careers for Ph.D. Life Scientists Outside of the Lab

Not everyone who completes a life sciences Ph.D. wants to continue working in a laboratory or in research. If this is the case for you, here are 12 careers for Ph.D. life scientists outside of the lab.

November 5, 2024

·

5 min read

·

Mark Terry

Pictured: AstraZeneca's manufacturing facility in

Obesity

AstraZeneca Bolsters Obesity Pipeline With Promising Early Data for Candidates

While expected and seen as largely incremental, Jefferies analyst Peter Welford in a Tuesday note to investors said the detailed data for three early-stage assets support moving them into Phase IIb studies and creates a “foothold” for AstraZeneca in the weight loss space.

November 5, 2024

·

3 min read

·

Tristan Manalac

Entrance to Vertex's office in Boston, Massachusetts

Earnings

Vertex Tops Q3 Forecast on Strength of Cystic Fibrosis Sales, Raises Full-Year Revenue Guidance

Coming off of a strong third quarter, Vertex Pharmaceuticals is nearing several important milestones, including the potential approvals of vanzacaftor triple in cystic fibrosis and the non-opioid therapy suzetrigine in pain—both slated for January 2025.

November 5, 2024

·

2 min read

·

Tristan Manalac

HeLa cervical cancer cells, stained with Coomassie blue, under microscope

Business

Lacks Family Lawsuits Seek Share of Profits Stemming from HeLa Cells

A suit against Novartis and Vitaris by Henrietta Lacks’ estate hinges on questions about the morality and legality of using the line for biopharmaceutical research.

November 5, 2024

·

7 min read

·

Sanjukta Mondal

FDA signage at its headquarters in Maryland

Regulatory

FDA Delays Decision on Merus Bispecific Antibody to Review CMC Information

Despite the PDUFA date being extended by three months for Merus’ zenocutuzumab, Truist Securities analyst Asthika Goonewardene in a Tuesday note to investors said the delay is not a cause for concern with an approval expected.

November 5, 2024

·

2 min read

·

Tristan Manalac

Pictured: A collage representing cell and gene the

Gene editing

Patient Death Taints Otherwise Positive Data for Beam’s Sickle Cell Gene Therapy

BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, but a patient death underscores the need for less-toxic preconditioning treatments.

November 5, 2024

·

3 min read

·

Annalee Armstrong

Group Of Employees Being Fired By Their Company.

Layoffs

Sana Biotechnology Will Lay Off Employees as It Shifts Pipeline

About a year after cutting staff by 29%, Sana Biotechnology will trim its workforce as it increases investment in its type 1 diabetes program and looks to extend its cash runway.

November 5, 2024

·

1 min read

·

Angela Gabriel

Press Releases

Expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine approved in Canada for adults aged 50-59 at increased risk

November 5, 2024

·

7 min read

Press Releases

Enpro Appoints Allison Aden to Board of Directors